PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2025Stroke26 citations

Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy

View Full Paper
SRSamantha RivetLCLeonid ChurilovNYNawaf Yassi

Key Points

Key points are not available for this paper at this time.

Abstract

When no-reflow occurred, clinical and radiological outcomes in patients with full angiographic recanalization were similar to patients with unsuccessful thrombectomy. Preventing or reversing no-reflow has the potential to augment the clinical benefit of reperfusion treatment in ischemic stroke.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rivet et al. (2025) studied this question.

synapsesocial.com/papers/69d77bb3aa68b335b4f31acfhttps://doi.org/10.1161/strokeaha.124.049574
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Endovascular treatment for large-core ischaemic stroke: a meta-analysis of randomised controlled clinical trials2023 · 57 citations
  2. 2Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases2013 · 101 citations
  3. 3Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection2015 · 5,877 citations
  4. 4Assessing Reperfusion and Recanalization as Markers of Clinical Outcomes After Intravenous Thrombolysis in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET)2009 · 145 citations
  5. 5Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials2017 · 465 citations